First FDA-approved treatment for HER2-positive colorectal cancer

“Historically, patients with HER2-positive metastatic colorectal cancer who have progressed following frontline therapy have had poor outcomes,” said John Strickler, M.D. and lead investigator of the MOUNTAINEER trial. “The FDA approval of a chemotherapy-free combination regimen that specifically targets HER2 is great news for these patients.”

Jan 20, 2023

Blog

Alliance pushes for Medicare coverage of genetic counseling

There is bi-partisan legislation pending in Congress that would fix this and help modernize Medicare and catch up with the advances in genetics and genomic medicine.

Nov 18, 2022

Blog

Does it matter where your colon cancer is located?

Understanding colon cancer sidedness is one more tool to help patients ask the right questions and advocate for the most effective treatment plan.

Apr 28, 2026

A smiling family of four, including John E., poses outdoors with a saddled brown horse at a mountain ranch, with pine-covered hills, fencing, and ski lift cables visible in the background on a sunny day.

Blog

John E.: Biomarker testing uncovered a pivotal treatment option

After a grim prognosis, biomarker testing revealed a targeted treatment option for John E. Learn how knowing your biomarkers can change what’s possible.

Jan 14, 2026